Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03702621 · ClinicalTrials.gov registry record · Phase 3

Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery

A Phase 3 study of Colorectal Surgery, sponsored by Indiana University.

Completed
Registry status
Phase 3
Development phase
90
Enrollment target
1
Study location

NCT03702621 is a Phase 3 study of Colorectal Surgery that has completed, run by Indiana University. The registered enrollment target is 90 participants, below the 319-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03702621, a Phase 3 study of Colorectal Surgery, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 3
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a colorectal surgery

Conditions Studied

Interventions

  • DRUG Bupivacaine Hydrochloride
  • DRUG liposomal Bupivacaine

Study Locations (1)

Indiana

  • Indiana University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2018-08-30
Est. Completion 2020-03-13
Phase Phase 3

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03702621

The ClinicalTrials.gov registry entry for NCT03702621 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 319-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (72% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Surgery appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine Hydrochloride is the first listed.

NCT03702621 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03702621 about?

NCT03702621 is a clinical study titled "Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery". The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a colorectal surgery

What is the current status of trial NCT03702621?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2018-08-30. Estimated completion is 2020-03-13.

What conditions does trial NCT03702621 study?

This clinical trial studies the following conditions: Colorectal Surgery.

What interventions are being tested in trial NCT03702621?

The interventions under investigation include: Bupivacaine Hydrochloride (DRUG), liposomal Bupivacaine (DRUG).

Who is sponsoring clinical trial NCT03702621?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03702621 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.